Nanotech

Quebec Critical Metals and Technology Conference Presentations Now Available for On-Demand Viewing

Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the March 30 th and March 31 st Quebec Virtual Investor Conference are now available for on-demand viewing.

REGISTER OR LOGIN NOW AT: https://bit.ly/3tWT2RP

The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company's resource section.

Companies are accepting 1x1 management meeting requests through April 5 th

March 30 th & 31 st Presentations:

Presentation Ticker(s)
Introduction: Martine Hebert, New York Delegate General Government of Quebec
Welcome Remarks: Nathalie Camden, Associate Deputy Minister of Mines of Quebec
Panel: Key Factors to Consider in Mining Investment Decisions:

Moderated by Investment Quebec with Appian Capital Advisory
Panel: Quebec 360 Degrees: From Mining to Recycling Batteries

Moderated by Investment Quebec with Nouveau Monde Graphite, Lithion Recycling, & Blue Solutions
Panel: A Partnership for a Turnaround of a Lithium Mine in Quebec with Sayona Piedmont

Moderated by Investment Quebec
Piedmont Lithium (Nasdaq: PLL) Sayona Mining (OTCQB: SYAXF)
Azimut Exploration Inc. Pink: AZMTF |TSXV: AZM
Voyager Metals Inc. Pink: VDMRF | TSXV: VONE
QC Copper & Gold Inc. OTCQB: QCCUF | TSXV: QCCU
Québec Nickel Corp. OTCQB: QNICF | CSE: QNI
Vision Lithium OTCQB: ABEPF | TSXV: VLI
Focus Graphite Inc. OTCQB: FCSMF | TSXV: FMS
Critical Elements Lithium Corp OTCQX: CRECF | TSXV: CRE
St-Georges Éco-Mining Corp OTCQB: SXOOF | CSE: SX
Lomiko Metals Inc. OTCQB: LMRMF | TSXV: LMR
Patriot Battery Metals Inc. OTCQB: PMETF | CSE: PMET
Commerce Resources Corp. OTCQX: CMRZF | TSXV: CCE
NanoXplore Inc. OTCQX: NNXPF | TSX: GRA
Doré Copper Mining Corp. OTCQX: DRCMF | TSXV: DCMC
Orford Mining Corp. Pink: ORMFF | TSXV: ORM
Imperial Mining Group OTCQB: IMPNF | TSXV: IPG
Renforth Resources Inc. OTCQB: RFHRF | CSE: RFR
Geomega Resources Inc. OTCQB: GOMRF | TSXV: GMA
HPQ-Silicon Resources Inc. OTCQX: HPQFF | TSXV: HPQ

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com .

About Virtual Investor Conferences ®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

Media Contact:
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com

Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GRA:CA,NNXPF
Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868

Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868

Phase 1b study designed to determine the safety and dose of NUV-868 in combination with olaparib or enzalutamide for the treatment of advanced solid tumors

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced it has dosed the first patient in a Phase 1b study of its BD2-selective BET inhibitor, NUV-868, in combination with olaparib.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Anixa Biosciences Inc.

Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing the body's immune system in the fight against cancer. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for early detection of solid tumours which is based on the body's immune response to the presence of a malignancy. The company is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs that genetically engineer patient's own immune cells to fight cancer.

NanoXplore Announces Appointment of New Board Member

NanoXplore Inc. ("NanoXplore" or the "Corporation") ( TSX: GRA and OTCQX: NNXPF ), a world-leading graphene company, announces the nomination of Ms. Catherine Loubier to its Board of Directors.

The nomination of Ms. Loubier followed an extensive search process by the Corporate Governance and Nominating Committee of the Board. The Board will continue to ensure its composition is well aligned to support senior management with the execution of its new five-year strategic growth plan and with the next phase of the Company's growth.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

NanoXplore Reports First Quarter 2023 Results and Unveils Its 5-year Strategic Plan

NanoXplore Inc. ("NanoXplore" or "the Corporation") (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for the first quarter ended September 30, 2022, and unveiled its 5-year strategic plan.

All amounts in this press release are in Canadian dollars, unless otherwise stated.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

NanoXplore Inc. to Release First Quarter Results and 5-Year Strategic Plan on November 14, 2022, After Market Close

NanoXplore Inc. (" NanoXplore " or the " Company ") (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of its first quarter ended September 30, 2022, on Tuesday, November 15, 2022, at 8:30 a.m. Eastern Time. The financial results and the 5-year strategic plan will be released on Monday November 14, 2022, after the market close.

Details of the Q1 Webcast

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update

Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update

Dosing underway for Phase 1 monotherapy study of NUV-868 in advanced solid tumors

Expect to initiate Phase 1b combination study of NUV-868 by the end of 2022

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×